Ftse Mib
33.984,20
-1,21%
DAX
20.046,30
-1,06%
S&P 500
5.919,43
0,80%
NASDAQ
19.392,69
0,00%
Bitcoin
102.256,55
2,19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Standard BioTools Inc (LAB) Standard BioTools Inc (LAB) Notizie

LAB

Standard BioTools (LAB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LAB
DataOraFonteTitoloSimboloCompagnia
19/12/202414:00GlobeNewswire Inc.Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LABStandard BioTools Inc
22/11/202402:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
14/11/202421:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LABStandard BioTools Inc
12/11/202422:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LABStandard BioTools Inc
07/11/202414:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
07/11/202414:00GlobeNewswire Inc.Standard BioTools Appoints Alex Kim as Chief Financial OfficerNASDAQ:LABStandard BioTools Inc
06/11/202423:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABStandard BioTools Inc
31/10/202413:01GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
30/10/202421:01GlobeNewswire Inc.Standard BioTools Reports Third Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
24/10/202420:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LABStandard BioTools Inc
16/10/202414:00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LABStandard BioTools Inc
24/09/202414:00GlobeNewswire Inc.Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K PlatformNASDAQ:LABStandard BioTools Inc
18/09/202414:00GlobeNewswire Inc.Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)NASDAQ:LABStandard BioTools Inc
03/09/202423:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
26/08/202414:00GlobeNewswire Inc.Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:LABStandard BioTools Inc
15/08/202402:54Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LABStandard BioTools Inc
06/08/202422:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
31/07/202422:02GlobeNewswire Inc.Standard BioTools Announces Senior Leadership ChangesNASDAQ:LABStandard BioTools Inc
31/07/202422:01GlobeNewswire Inc.Standard BioTools Reports Second Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
17/07/202414:01GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024NASDAQ:LABStandard BioTools Inc
03/06/202423:20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
03/06/202423:19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LABStandard BioTools Inc
29/05/202422:34Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LABStandard BioTools Inc
28/05/202422:01GlobeNewswire Inc.Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan CustomersNASDAQ:LABStandard BioTools Inc
21/05/202423:16Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:LABStandard BioTools Inc
21/05/202423:15Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:LABStandard BioTools Inc
20/05/202414:00GlobeNewswire Inc.Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LABStandard BioTools Inc
20/05/202412:03Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:LABStandard BioTools Inc
10/05/202423:16Edgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:LABStandard BioTools Inc
08/05/202422:01GlobeNewswire Inc.Standard BioTools Reports First Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LAB

La tua Cronologia

COIN
HUNTGBP
HUNT Token
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network